Portal de Periódicos da CAPES

Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up

2021; Oxford University Press; Volume: 43; Issue: 12 Linguagem: Inglês

10.1093/eurheartj/ehab767

1522-9645

Mikhael F. El‐Chami, Lindsay Bockstedt, Colleen Longacre, Lucas Higuera, Kurt Stromberg, George H. Crossley, Robert Kowal, Jonathan P. Piccini,

Cardiomyopathy and Myosin Studies

Clinical trials have demonstrated the safety and efficacy of the Micra leadless VVI pacemaker; however, longer-term outcomes in a large, real-world population with a contemporaneous comparison to transvenous VVI pacemakers have not been examined. We compared reinterventions, chronic complications, and all-cause mortality at 2 years between leadless VVI and transvenous VVI implanted patients.